Peptides vs SARMs: A Technical Comparison Review of Purity, Manufacturing, and Sourcing Specifications
Peptides vs SARMs: A Technical Comparison Review of Purity, Manufacturing, and Sourcing Specifications For researchers evaluating bioactive compounds, purity specifications are the critical differentiator between peptides and SARMs. Pharmaceutical-grade peptides typically achieve >98% purity via HPLC validation, while SARMs often exhibit lower batch consistency. Manufacturing protocols diverge significantly: peptides require lyophilized storage at -20°C to maintain stability, whereas SARMs demand solvent-based handling. Sourcing analysis reveals that ISO 9001-certified peptide suppliers provide comprehensive COAs and third-party mass spectrometry reports—a standard rarely matched by SARM vendors. Market trends show peptide brands prioritizing GMP compliance and endotoxin testing, establishing clearer regulatory pathways. For optimal logistics, peptides require cold-chain shipping with desiccants, while SARMs necessitate controlled substance documentation. This technical review emphasizes that rigorous purity testing and transparent certification remain paramount for research-grade peptide selection.